Breaks Categories: Stock Spotlights

TuesdaySep 25, 2018 2:58 pm

HempNewsBreaks – BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Platform Solves Unique Challenges Faced by the Cannabis Industry

BLOCKStrain Technology (TSX.V: DNAX) (OTC: BKKSF), through its easily integrated BLOCKStrain platform, offers the cannabis market a single-source accountability system. A recent article discussing the company’s innovative platform reads: “While supply chain transparency and verification are ongoing issues for various industries, in an emerging industry like the cannabis market, in which regulations are still being established and the proverbial kinks are still being worked out, the need for a reliable means of seed-to-sale tracking is even more acute. … Until recently, cannabis products were largely available only on the black market. As cannabis availability and legalization now continue to expand…

Continue Reading

FridaySep 21, 2018 2:14 pm

HempNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Innovative Platform Demonstrates Excellent Results in Delivery of APIs to the Brain

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative delivery platform, DehydraTECH™, has demonstrated excellent results in delivery of nicotine to the brain in a recent lab study. An article discussing this reads, “The new report confirmed first generation results of in vivo tests on live animals showing that DehydraTECH™ was able to deliver more active pharmaceutical ingredients (APIs) across the brain’s protective blood brain barrier, as reported in an article published by the CFN Media Group (http://cnw.fm/0l9eM). Because of certain similarities in physical structure between the nicotine molecule and several of the drugs used to treat diseases such as Huntington’s, Parkinson’s,…

Continue Reading

FridaySep 21, 2018 2:07 pm

HempNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Strategically Employs R&D Strategy to Achieve Increased Productivity

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) aims to give its investors more bang for their buck when it comes to research and development (“R&D”), as it has been proven that smaller companies achieve higher R&D productivity. A recent article discussing the company reads: “PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) has taken this advice to heart. The health sciences company has three distinct research programs underway. Top of the line is a non-opioid pain treatment based on cannabinoids to be administered through a proprietary nose-to-brain, soluble gel (Sol-gel) drug delivery system. The research…

Continue Reading

WednesdaySep 19, 2018 12:43 pm

HempNewsBreaks – Sugarmade, Inc. (SGMD) Strategic Investment Offers Great Opportunity in the Cannabis Sector

Hydroponic supply company Sugarmade (OTC: SGMD) earlier this month reported that it will be investing an estimated $1 million in capital in Hempistry, Inc. A recent article further discussing the company’s investment reads: “One of the primary reasons that the Hempistry project is such an attractive entry point for Sugarmade is the hemp grown by the company, which contains high levels of CBD while containing low levels (less than 0.3 percent) of THC. Both are natural compounds found in cannabis, but they create vastly different effects when consumed. CBD is a non-psychoactive compound that doesn’t produce the problematic ‘high’ associated…

Continue Reading

WednesdaySep 19, 2018 12:35 pm

HempNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Has Achieved DTC, CNS Eligibility to Simplify Settlement, Boost Liquidity

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF), a premium functional food and beverage business based in Vancouver, British Columbia, was recently awarded full DTC (Depository Trust Company) and CNS (Continuous-Net-Settlement) eligibility for its common shares listed for trading on the U.S. OTCQX® Best Market. A recent article discussing this reads, “Phivida’s expectation is that achieving DTC and CNS eligibility will simplify and fast-track settlement for investors while boosting the liquidity of its common shares on the OTC Market. CNS eligibility ensures that all DTC eligible trades and cash balances are centralized, cleared and settled in an efficient and systematic way.” To…

Continue Reading

WednesdaySep 19, 2018 11:22 am

HempNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Expands Diverse Portfolio, Enters Pet Care Market

Cannabis Strategic Ventures (OTC: NUGS) recently entered the pet care market through its acquisition of The Asher House Pet CBD brand from The Asher House LLC, as detailed in a recent news release (http://cnw.fm/LAq54). A recent article discussing the company’s acquisition reads: “Under the terms of the brand acquisition agreement, Cannabis Strategic Ventures will acquire controlling interest in the Asher House Pet CBD line, a brand of U.S. hemp-derived cannabidiol (CBD) supplements for pets that continues to gain national attention and is expanding internationally. Lee Asher and Luke Barton, founders of The Asher House, are currently on a whirlwind cross-country tour,…

Continue Reading

FridaySep 14, 2018 2:40 pm

HempNewsBreaks – Medical Cannabis Payment Solutions (REFG) Expands its Reach Within the Legalized Cannabis Sector

Medical Cannabis Payment Solutions (OTC: REFG), through its Green FinCEN-compliant processing system, is providing the legalized marijuana industry an alternative to traditional banking A recent article discussing the company reads: “Medical Cannabis Payment Solutions (OTC: REFG) has expanded its presence in the legalized cannabis space from its core Green FinCEN-compliant processing system, which creates a digital and cashless way for dispensaries and other legalized merchants to do business outside of the traditional banking system. Online signup has generated more applications for Green, according to REFG (http://cnw.fm/DTY9n).” To view the full article, visit http://cnw.fm/ectF9 About Medical Cannabis Payment Solutions Medical Cannabis…

Continue Reading

FridaySep 14, 2018 2:34 pm

HempNewsBreaks – BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Revolutionizes Visibility, IP Protection in the Cannabis Supply Chain

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF), through its easily integrated BLOCKStrain platform, enables cannabis growers to defend their intellectual property rights with an authentic, verifiable chain of evidence embedded in the blockchain from genome to sale. A recent article discussing the company reads: “That’s where BLOCKStrain’s platform comes in by providing a gene-registration defense of intellectual property rights and establishing historical proof of ownership. That’s huge for cannabis growers seeking to develop their own brands for an increasingly astute and knowledgeable base of loyal consumers. The authenticity of a particular cannabis strain is followed from genome to sale, providing…

Continue Reading

FridaySep 14, 2018 11:32 am

HempNewsBreaks – Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) Unveils New Beverage Line

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) develops and distributes nature-based products that boost brain function, elevate health, and enhance productivity. The company recently launched the first two flavors in its new line of beverages. A recent article discussing the beverages reads: “Pear guava has proven so popular that the company is in its second run of production. The other flavor is peach mango. Both beverages include the new superfood lion’s mane mushroom, which is part of Koios’ reformulated and improved range of cognitive-enhancing drinks. Other flavors soon to come in the same line are blood orange and apricot vanilla.”…

Continue Reading

FridaySep 14, 2018 11:26 am

HempNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Advances Nature Identical Peptides Testing

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is steadfast in its mission of developing preventive therapies for health-conscious consumers who want nature-based products. A recent article discussing the company reads, “In recent months, the company has advanced the testing of its Nature Identical™ peptides toward the treatment and prevention of cancers such as the glioblastoma, the disease that took the life of Sen. John McCain. The company’s research team identified eight peptide candidates for the anticipated line of wellness products earlier this year, building on analysis of the Caribbean blue scorpion whose venom is widely reputed…

Continue Reading